Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1569
HER2amp
Basal A
Omipalisib
PI3K
PI3K
7449.086
uM
0.02058
0.02159
-0.0287 -0.0260 1.0582 0.5879
0.9970
2.0500
HCC1569
HER2amp
Basal A
Oxaliplatin
DNA cross-linker
DNA cross-linker
7825.011
uM
4.73660
11.85220
-0.1553 -0.2893 0.4977 0.4115
0.9758
1.9334
HCC1569
HER2amp
Basal A
Oxaliplatin
DNA cross-linker
DNA cross-linker
9347.011
uM
8.21820
18.530
-0.2089 -0.3213 0.6104 0.3801
0.9820
1.6648
HCC1569
HER2amp
Basal A
Oxamflatin
HDAC
HDAC
10872.147
uM
0.81346
2.15590
-0.7963 -0.8993 1.0558 0.5386
0.9907
1.6255
HCC1569
HER2amp
Basal A
Oxamflatin
HDAC
HDAC
12523.147
uM
2.49980
3.57780
-0.8879 -0.9031 2.8779 0.4262
0.9979
0.9214
HCC1569
HER2amp
Basal A
PD 98059
MEK
MAPK
12523.152
uM
inf
inf
1.0310 1.0310 0.0000 -0.0401
-9.8795
0.8423
HCC1569
HER2amp
Basal A
PD 98059
MEK
MAPK
10872.152
uM
inf
inf
0.7580 0.7580 0.0000 0.1442
0.1498
1.5916
HCC1569
HER2amp
Basal A
PD173074
FGFR1/3
RTK
10442.093
uM
6.56210
11.29660
-0.8026 -1.0000 2.0225 0.2116
0.9951
1.6861
HCC1569
HER2amp
Basal A
PD184352
MEK
MAPK
10872.155
uM
inf
inf
0.9297 0.9297 0.0000 0.0301
0.0000
1.5288
HCC1569
HER2amp
Basal A
PD184352
MEK
MAPK
10872.155
uM
inf
inf
0.9297 0.9297 0.0000 0.0301
0.0000
1.5288
HCC1569
HER2amp
Basal A
PD184352
MEK
MAPK
12523.155
uM
inf
inf
0.9460 0.9460 0.0000 0.0104
0.1224
1.0583
HCC1569
HER2amp
Basal A
PD184352
MEK
MAPK
12523.155
uM
inf
inf
0.9460 0.9460 0.0000 0.0104
0.1224
1.0583
HCC1569
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7449.095
uM
inf
inf
0.9175 0.9175 0.0000 0.0613
0.3814
2.0118
HCC1569
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7448.095
uM
inf
203.57140
0.3634 0.5672 4.9997 0.1044
0.7575
2.9105
HCC1569
HER2amp
Basal A
Pertuzumab
7447.102
mg/ml
inf
124.99960
0.8861 0.6968 0.1346 0.0581
0.6369
1.6467
HCC1569
HER2amp
Basal A
PS-1145
IKK
NFKB
7449.065
uM
inf
inf
0.9600 0.9600 0.0000 0.0227
0.1556
2.0765
HCC1569
HER2amp
Basal A
PS-1145
IKK
NFKB
7448.065
uM
inf
1000.00000
0.9134 0.9101 5.0000 -0.0012
0.7365
2.6104
HCC1569
HER2amp
Basal A
Purvalanol A
CDK1
CDK
7449.067
uM
inf
inf
0.8522 0.8522 0.0000 0.0013
0.3467
1.9771
HCC1569
HER2amp
Basal A
Purvalanol A
CDK1
CDK
7448.067
uM
inf
8.38460
0.5825 0.6294 5.0000 0.0866
0.9666
2.8462
HCC1569
HER2amp
Basal A
Purvalanol A
CDK1
CDK
7447.067
uM
18.52570
22.07880
-0.3005 -0.3059 2.7205 0.2178
0.9963
1.5637
HCC1569
HER2amp
Basal A
Ribavirin
15388.211
uM
inf
inf
0.9655 0.9655 0.0000 0.0072
-0.0182
1.5247
HCC1569
HER2amp
Basal A
SB-3CT
MMP2/9
MMP
12523.168
uM
inf
inf
1.0409 1.0409 0.0000 -0.0083
-0.040
0.9035
HCC1569
HER2amp
Basal A
SB-3CT
MMP2/9
MMP
10872.144
uM
inf
25.11680
0.8015 0.8012 4.9407 -0.0061
0.8436
1.5447
HCC1569
HER2amp
Basal A
Selumetinib
MEK
MAPK
10872.155
uM
inf
inf
0.9648 0.9648 0.0000 0.0039
0.1215
1.5288
HCC1569
HER2amp
Basal A
Selumetinib
MEK
MAPK
12523.155
uM
inf
inf
0.8410 0.8410 0.0000 0.0432
0.2612
1.0583